Source: MarketScreener

Cardionomic: Cardionomic Announces First Patients Enrolled in CPNS Pilot Study

(marketscreener.com) MINNEAPOLIS, April 15, 2021 /PRNewswire/ -- Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce initial enrollment in their Cardionomic Pulmonary Neuromodulation System Pilot Study. The study will evaluate the safety and performance of the CPNS in patients suffering from Acute Decompensated Heart Failure,...https://www.marketscreener.com/news/latest/Cardionomic-Announces-First-Patients-Enrolled-in-CPNS-Pilot-Study--32979286/?utm_medium=RSS&utm_content=20210415

Read full article ยป
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Steve Goedeke's photo - President & CEO of Cardionomic

President & CEO

Steve Goedeke

CEO Approval Rating

86/100

Read more